30th BioPharma Drug Discovery Nexus Conference

May 25th & 26th 2027

DoubleTree by Hilton Hotel Philadelphia Center City, USA

0
Days
0
Hours
0
Mins
0
Secs
Be A Participant

Driving Progress Across the Drug Discovery Landscape



The BioPharma Drug Discovery Nexus is an exclusive conference that brings together leading drug discovery scientists, R&D executives, and biotech & innovative technology partners from across the biopharmaceutical industry.

The conference agenda is meticulously curated to address critical challenges across the drug discovery continuum from target identification and validation to lead optimization and translational science. It highlights emerging scientific breakthroughs, evolving discovery platforms, and real-world strategies adopted by pioneering organizations that are shaping the future of therapeutic innovation.

A Premium, All-Inclusive Experience

Every delegate is treated as a VIP. From curated networking sessions to carefully designed experiences, the Nexus fosters both professional engagement and personal comfort, creating the ideal environment for productive dialogue and long-lasting connections.

Driving Conversations in Drug Discovery

This is not a conventional tradeshow. The Nexus is purposefully structured to bring together senior leaders in a focused setting that supports strategic discussions, peer learning, and professional exchange.

Curated One-to-One Engagements

Build meaningful connections through dedicated one-to-one meetings with fellow delegates during designated networking hours throughout the conference. Whether exploring potential collaborations, exchanging expertise, or discussing shared challenges, these flexible meetings help you make the most of your time and create valuable professional relationships.

Who Should Attend?

Seniority Level
10% 35% 25% 20% 10%
C-Level Executives (10%)
Directors / Senior Directors (35%)
VPs / Heads (25%)
Senior Managers / Managers (20%)
Leads / Specialists (10%)
Demographics
51% 25% 18% 5% 3%
East Coast (51%)
West Coast (25%)
Central USA (18%)
Europe (5%)
Others (3%)
  • Biology
  • Neuroscience and Preclinical Research
  • Protein Engineering
  • Target Biochemistry
  • Computational Designing
  • In Vivo Pharmacology
  • Research & Product Development
  • Drug Discovery
  • Pharmacology and Pharmacokinetics
  • Medicinal Chemistry
  • Translational Research
  • High-Throughput Protein Expression
  • Biomarker Research
  • R&D
  • Manufacturing in Cell Therapy
  • Drug Design
  • Bioinformatics and AI/ML
  • Therapeutic Antibodies
  • Structural Chemistry
  • Molecular Design
  • Preclinical Development
  • Global Upstream and Cell Line Development
  • Nonclinical Development
  • Oncology Cell Therapy Innovation
  • DMPK
  • Nucleic Acid Drug Discovery
  • Cancer Biology
  • Toxicology
  • Vaccine Immunology
  • Modeling & Simulation
  • mRNA Protein Therapeutics
  • Small Molecule Research
  • Data Science, CADD
  • Synthetic Biology
  • Machine Learning
  • Molecular Modelling

Our Industry Leaders

Meet the Innovators Driving the Next Era of Drug Discovery

Kas Subramanian, Ph.D.
Kas Subramanian, Ph.D.

Chief Executive Officer

Differentia Bio

LinkedIn
Dr Ridhima Lal
Dr Ridhima Lal

Principal Scientist

Aptamer Group

LinkedIn
Dr. Kevin Liu
Dr. Kevin Liu

Director, Business Development, CRO Service

WuXi Biologics

LinkedIn
Alexander Sercel, Ph.D.
Alexander Sercel, Ph.D.

Director, West Coast Business Development

Southern Model Organisms

LinkedIn
Scott Hutton
Scott Hutton

Business Development Advisor, XtalPi Future Chemistry Services

XtalPi

LinkedIn
Philip M Arlen
Philip M Arlen

President and Chief Executive Officer

Precision Biologics

LinkedIn
Riccardo Calandrelli
Riccardo Calandrelli

Principal Bioinformatics Scientist II

Athos Therapeutics

LinkedIn
Harshini Neelakantan, Ph.D.
Harshini Neelakantan, Ph.D.

Executive Director—Research and Development

Ridgeline Therapeutics

LinkedIn
Rameshwar U. Kadam, Ph.D
Rameshwar U. Kadam, Ph.D

Senior Scientist II

Johnson & Johnson Innovative Medicine

LinkedIn
Shicheng Guo
Shicheng Guo

Senior Director, Translational Genetics and Data Science

Arrowhead Pharmaceuticals

LinkedIn
Dayson Friaca Moreira, Ph.D.
Dayson Friaca Moreira, Ph.D.

Sr Scientist

Neurocrine Biosciences

LinkedIn
Igor Nasonkin
Igor Nasonkin

Co-Founder & CEO

Phythera Therapeutics, Inc

LinkedIn
Misagh Naderi, PhD
Misagh Naderi, PhD

Co-Founder & CEO

Glintlab

LinkedIn
Misagh Naderi, PhD
Dr. Fengbo Ren

Founder and CEO

Fovus

LinkedIn
Arvind Thiagarajan
Arvind Thiagarajan

Co-Founder & CTO

Tessel Bio

LinkedIn
Roshanak Tolouei Semnani
Roshanak Tolouei Semnani

Executive Director Translational Research

Precigen

LinkedIn
Shradha Wali, Ph.D
Shradha Wali, Ph.D

Senior Scientist, Preclinical Development

Stereo Biotherapeutics

LinkedIn
Scott Johnson
Scott Johnson

Scientific Associate Director

Bristol Myers Squibb

LinkedIn

6 Reasons to Attend

Gain Insight into Cutting-Edge Science & Technologies

Discover the latest innovations in target discovery, novel modalities, and AI-enabled drug design.

Learn from Industry Trailblazers

Hear proven strategies and real-world insights from leading drug discovery and R&D experts.

Address Real Drug Discovery Challenges

Explore solutions to key challenges across target validation, optimization, and early development.

High-Value, Curated Networking

Connect with senior discovery leaders and solution providers in an exclusive, invitation-only setting.

Practical, Actionable Takeaways

Take home applicable frameworks and case studies to strengthen discovery productivity.

Stay Ahead of Market & Research Trends

Keep pace with emerging scientific, technological, and strategic trends shaping drug discovery.

What to expect at
the 2027 Edition

Our 2027 agenda is built around Two core themes, each designed to address the most pressing challenges and opportunities in modern drug discovery and translational research. These themes guide scientific discussions, spark innovation, foster collaboration, and provide actionable strategies to accelerate R&D, enhance candidate development, and drive meaningful impact across the industry.

  • Early Discovery, Novel Targets And Therapeutic Modalities
  • AI, Computational Science & Data-Driven Drug Discovery

Industry Leaders and Innovators Who Make Things Happen

  • Drive Innovation: Senior executives and innovators actively implementing new technologies, strategies, and operational solutions in supply chain and logistics.
  • Stay Ahead: Professionals seeking the latest insights on market trends, regulatory developments, and emerging best practices.
  • Collaborate Strategically: Leaders looking to form partnerships that solve complex supply chain and operational challenges.
  • Accelerate Performance: Experts focused on enhancing efficiency, optimizing processes, and driving measurable results across the supply chain.

Your opportunity to gain insights, practical strategies, and valuable industry connections.

  • Engage with Industry Leaders
  • Hands-On Learning
  • Shape the Conversation
  • Build Strategic Connections
  • High-level plenaries with leading drug discovery experts
  • Hands-on sessions exploring emerging technologies and innovative approaches
  • Targeted networking designed to foster collaborations and scientific partnerships

Our Previous Partners

Showcase Your Solutions at the 30th Drug Discovery Nexus Conference

Take advantage of exclusive opportunities to showcase your scientific expertise, present breakthrough research, and highlight innovative drug discovery solutions. Lead high-level discussions with senior researchers, biotech innovators, and pharma decision-makers, positioning your organization at the forefront of drug discovery and translational science.

At the Nexus, your participation is active, not passive. Engage directly with decision-makers through presentations, panel and roundtable discussions, solution demonstrations, and targeted 1:1 meetings. This is your chance to influence the conversation, showcase your capabilities, and build meaningful partnerships that deliver real operational impact.

Schedule At a Glance

08:00 am - 09:00 am
Registration
09:00 am - 09:15 am
Welcome & Chairperson Address
09:15 am - 09:45 am
Panel Discussion 1
09:50 am - 10:20 am
Panel Discussion 2
10:25 am - 11:40 am
Mid-Morning Networking Session
Exhibition + 1:1 Meetings
11:45 am - 12:05 pm
Presentation 1
12:10 pm - 12:30 pm
Presentation 2
12:35 pm - 12:55 pm
Presentation 3
01:00 pm - 02:00 pm
Lunch Break
02:05 pm - 02:35 pm
Panel Discussion 3
02:40 pm - 02:55 pm
Presentation 4
03:00 pm - 03:30 pm
Panel Discussion 4
03:30 pm - 03:35 pm
Session Closing Remarks
03:35 pm - 05:00 pm
Afternoon Networking Session & Drinks Reception
Exhibition + 1:1 Meetings
08:00 am - 09:00 am
Registration
09:00 am - 09:15 am
Welcome & Chairperson Address
09:15 am - 09:45 am
Panel Discussion 1
09:50 am - 10:20 am
Panel Discussion 2
10:25 am - 11:40 am
Mid-Morning Networking Session
Exhibition + 1:1 Meetings
11:45 am - 12:05 pm
Presentation 1
12:10 pm - 12:30 pm
Presentation 2
12:35 pm - 12:55 pm
Presentation 3
01:00 pm - 02:00 pm
Lunch Break
02:05 pm - 02:35 pm
Panel Discussion 3
02:40 pm - 02:55 pm
Presentation 4
03:00 pm - 03:30 pm
Panel Discussion 4
03:30 pm - 03:35 pm
Session Closing Remarks
03:35 pm - 05:00 pm
Afternoon Networking Session
Exhibition + 1:1 Meetings

0

+

Seats

0

Hours

0

+

Speakers

0

+

Exhibitors

Testimonials

Frequently Asked Questions

Got Questions? We’ve Got Answers

The event is designed for senior professionals from pharmaceutical and biotech companies, as well as research organizations, technology providers, and collaborators supporting the drug discovery ecosystem.

The audience includes professionals involved in target discovery, translational research, medicinal chemistry, biology, screening, assay development, data science, AI-enabled discovery, and cross-functional collaboration.

The event brings together a carefully curated, senior-level audience of pharmaceutical and biotech decision-makers, alongside relevant discovery service providers and solution providers. With approximately 80% of attendees representing pharmaceutical and biotech organizations and 20% representing service and solution providers, the event offers a strong balance between industry stakeholders and potential partners.

Unlike a large-scale, open trade show, the BioPharma Drug Discovery Nexus is designed around focused, relationship-driven conversations with relevant decision-makers. The event provides a dedicated environment for practical discussions, sharing industry insights, exploring discovery solutions, building meaningful connections, and developing new business opportunities.

The event offers a range of participation and partnership options to suit different objectives, including Delegate/Networking Passes, Dedicated Presentations, Panel Discussions, Roundtables, Pre-arranged 1:1 Meetings, Exhibition, Marketing Campaigns, Sponsorship Packages, and customized participation opportunities.

Pharmaceutical and biotech companies can participate as delegates or through speaking formats such as dedicated presentations, panels, and roundtables.

Service providers and solution providers can choose from delegate participation, company presentations, panels, roundtables, exhibition, 1:1 meetings, marketing campaigns, sponsorship, and customized partnership options.

You can gain actionable insights and practical knowledge while exploring current industry priorities, benchmarking strategies, discovering emerging technologies, and exchanging experiences with peers.

The event also provides opportunities to build valuable professional relationships, identify potential partners, explore relevant solutions, and develop new business connections.

Key areas include target and biomarker discovery, hit-to-lead optimization, translational biology, screening technologies, assay development, medicinal chemistry, AI and data-driven discovery, computational biology, platform technologies, and collaboration across discovery teams.

Sessions focus on practical challenges in early-stage research, evolving discovery workflows, strategies to improve productivity and decision-making, smarter use of data and AI, and emerging technologies and approaches shaping the future of drug discovery.

Yes. Dedicated 1:1 meetings are available through the meeting platform.

Participants can review profiles, identify relevant professionals, and connect and interact before the event to discuss their interests and arrange meetings in advance. The platform also allows participants to continue interacting after the event, helping maintain relevant connections and conversations beyond the conference.

Yes. You can participate as a delegate and access the conference sessions, curated networking opportunities, and available 1:1 meetings without taking an exhibition or sponsorship package.

This is an ideal option if your primary objective is to learn, network, exchange experiences, meet relevant professionals, and explore potential business relationships.

Yes. Companies can explore speaking opportunities including panel discussions, dedicated presentations, roundtables, and other available formats. These opportunities allow participants to share expertise, present case studies, discuss industry challenges, and contribute to practical conversations with senior professionals.

Yes. Exhibition and sponsorship opportunities are available for service providers and solution providers looking to increase their visibility within the pharmaceutical and biotech community.

These opportunities are designed to provide maximum visibility, relevant lead generation, direct access to decision-makers, and opportunities to showcase solutions and expertise throughout the event.

You can visit the BioPharma Drug Discovery Nexus website to explore the event and available participation opportunities.

You can also contact our team at enquiry@nexus-conference.com to request the latest prospectus, discuss your objectives, explore the most suitable participation option, or proceed with registration.

Venue

DoubleTree by Hilton Hotel Philadelphia Center City

Name: DoubleTree by Hilton Hotel Philadelphia Center City

Address: 237 South Broad Street, Philadelphia, Pennsylvania, 19107-5686, USA

CONFERENCE REGISTRATION

Secure your spot today.